Evidence map›Paper›PMID 35196812›Full record

ArticleMicrobiology spectrum2022

Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.

Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Chien-Wen Chen, Shan-Shan Hsieh, Kuo-Sheng Hung, Sheng-Hui Tang, Cherng-Lih Perng and 3 more

Abstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Integrating Genomic Data into Test-negative Designs for Estimating Lineage-specific COVID-19 Vaccine Effectiveness.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hsing-Yi Chung *Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Ming-Jr Jian *Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chih-Kai ChangDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Jung-Chung LinDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Kuo-Ming YehDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chien-Wen ChenDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Shan-Shan HsiehDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Kuo-Sheng HungCenter for Precision Medicine and Genomics, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Sheng-Hui TangDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Cherng-Lih PerngDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Feng-Yee ChangDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chih-Hung WangDepartment of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Hung-Sheng ShangDivision of Clinical Pathology, Department of Pathology, Tri-Service General Hospitalgrid.278244.f, National Defense Medical Center, Taipei, Taiwan, Republic of China.ORCID 0000-0002-4831-1866

Funding

Tri-Service General Hospital (TSGH) TSGH-D-111086
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Many variants of SARS-CoV-2 have been reported, some of which have increased transmissibility and/or reduced susceptibility to vaccines. There is an urgent need for variant phenotyping for epidemiological surveillance of circulating lineages. Whole-genome sequencing is the gold standard for identifying SARS-CoV-2 variants, which constitutes a major bottleneck in developing countries. Methodological simplification could increase epidemiological surveillance feasibility and efficiency. We designed a novel multiplex real-time reverse transcriptase PCR (RT-PCR) to detect SARS-CoV-2 variants with S gene mutations. This multiplex PCR typing method was established to detect 9 mutations with specific primers and probes (ΔHV 69/70, K417T, K417N, L452R, E484K, E484Q, N501Y, P681H, and P681R) against the receptor-binding domain of the spike protein of SARS-CoV-2 variants.

Indexed as

COVID-19Epidemiological MonitoringHumansMutationPandemicsPublic HealthReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Spike Glycoprotein, CoronavirusTaiwanWhole Genome SequencingSpike Glycoprotein, CoronavirusE484KE484Repidemiological surveillanceK417NK417TL452RN501YP681HP681RSARS-CoV-2VOC genotypingΔHV 69/70

Identifiers

PMID35196812
PMCPMC8865422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.